DNAJC10 is an independent prognostic factor in gliomas
(A) Univariate and multivariate Cox regression results of DNAJC10 and other clinicopathological factors of glioma patients. (B) Establishment of the DNAJC10-based nomogram model. (C–E) 1/3/5-year OS calibration curves indicate the predictive robustness of the DNAJC10-based nomogram prognostic model in the TCGA (C), CGGAseq1 (D) and CGGAseq2 (E) glioma cohorts.